CHRONIC GOUT
Clinical trials for CHRONIC GOUT explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GOUT trials appear
Sign up with your email to follow new studies for CHRONIC GOUT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for Tough-to-Treat gout
Disease control CompletedThis study tested a gout medication called pegloticase (KRYSTEXXA) given every 4 weeks along with weekly methotrexate pills in 54 adults with severe gout that didn't respond to standard treatments. The goal was to see if this combination could lower uric acid levels and keep them…
Matched conditions: CHRONIC GOUT
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New monthly shot shows promise for Tough-to-Treat gout
Disease control CompletedThis study tested a new medicine called SEL-212 for people with chronic gout that doesn't get better with standard treatments. 153 adults received either one of two doses of SEL-212 or a placebo every 28 days for about 6 months. The goal was to see if the drug could lower uric ac…
Matched conditions: CHRONIC GOUT
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New infusion drug shows promise for stubborn gout
Disease control CompletedThis Phase 3 trial tested a drug called SEL-212 in 112 adults with chronic gout that didn't improve with standard treatments. Participants received either a low or high dose of SEL-212 or a placebo by IV infusion every 28 days for about 6 months. The main goal was to see if the d…
Matched conditions: CHRONIC GOUT
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 26, 2026 15:54 UTC